Want to see KURA full AI Analyst Report?
Kura Oncology (KURA) Financial Statements
Kura Oncology Financial Overview
Kura Oncology's market cap is currently $912.74M. The company's EPS TTM is $-3.37; its P/E ratio is -3.04; Kura Oncology has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 67.48M | $ 53.88M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 67.42M | $ 53.88M | $ -849.00K | $ 0.00 | $ 0.00 |
| Operating Income | $ -303.63M | $ -193.19M | $ -165.80M | $ -139.87M | $ -131.26M |
| EBITDA | $ -275.82M | $ -169.50M | $ -150.23M | $ -134.85M | $ -129.49M |
| Net Income | $ -278.67M | $ -173.98M | $ -152.63M | $ -135.84M | $ -130.47M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 667.24M | $ 727.39M | $ 423.96M | $ 437.99M | $ 517.96M |
| Total Assets | $ 738.36M | $ 760.16M | $ 448.94M | $ 456.31M | $ 534.05M |
| Total Debt | $ 20.46M | $ 16.59M | $ 17.20M | $ 14.02M | $ 6.88M |
| Net Debt | $ -128.64M | $ -207.87M | $ -20.12M | $ -37.78M | $ -83.80M |
| Total Liabilities | $ 564.23M | $ 346.52M | $ 51.66M | $ 36.03M | $ 27.44M |
| Stockholders' Equity | $ 174.13M | $ 413.64M | $ 397.27M | $ 420.28M | $ 506.61M |
| Cash Flow | |||||
| Free Cash Flow | $ -70.70M | $ 133.84M | $ -124.99M | $ -110.69M | $ -105.70M |
| Operating Cash Flow | $ -64.06M | $ 134.32M | $ -124.82M | $ -110.06M | $ -104.55M |
| Investing Cash Flow | $ -13.10M | $ -101.59M | $ 15.56M | $ 32.63M | $ -126.83M |
| Financing Cash Flow | $ 1.79M | $ 154.42M | $ 94.78M | $ 38.56M | $ -3.44M |
Currency in USD